Browse

Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy

DC Field Value Language
dc.contributor.authorLee, Hakmin-
dc.contributor.authorLee, Minseung-
dc.contributor.authorLee, Sang Eun-
dc.contributor.authorByun, Seok-Soo-
dc.contributor.authorKim, Hyeon Hoe-
dc.contributor.authorKwak, Cheol-
dc.contributor.authorHong, Sung Kyu-
dc.date.accessioned2018-05-29T01:33:07Z-
dc.date.available2018-05-29T10:37:03Z-
dc.date.issued2018-04-16-
dc.identifier.citationBMC Cancer, 18(1):427ko_KR
dc.identifier.issn1471-2407-
dc.identifier.urihttps://hdl.handle.net/10371/141241-
dc.description.abstractAbstract

Background
The prognosis of patients with pathologic stage T3a renal cell carcinoma (RCC) that is up-staged from a small renal tumor remains controversial. We evaluated the prognosis of patients with RCC who were up-staged from clinical stage T1 to pathologic stage T3a.

Methods
We retrospectively reviewed the data of 3431 patients who were surgically treated for clinical stage T1 RCC. The survival outcomes were compared using Kaplan-Meier and Cox proportional analyses.

Results
Among the clinical stage T1 patients, 215 (6.3%) were finally up-staged to pathologic stage T3a. Patient age (HR 1.302, 95% CI 1.018–1.046, p <  0.001), tumor diameter (HR 1.686, 95% CI 1.551–1.834, p <  0.001), and hilar location (HR 1.765, 95% CI 1.147–2.715, p = 0.010) were significantly associated with upstaging. Kaplan-Meier analyses showed significantly shorter recurrence-free, cancer-specific and overall survivals (all p <  0.001) in patients who were up-staged. Multivariate Cox analyses revealed pathologic upstaging as an independent predictor of shorter recurrence-free (HR 2.195, 95% CI 1.459–3.300, p <  0.001), cancer-specific (HR 2.238, 95% CI 1.252–4.003, p = 0.007), and overall survivals (HR 1.632, 95% CI 1.029–2.588, p = 0.037). Subgroup analysis of pathologic stage T3a showed no significant difference in survival of the partial nephrectomy group when compared to the radical nephrectomy group (all p > 0.5).

Conclusions
Patients up-staged from clinical stage T1 to pathologic stage T3a RCC showed shorter survival outcomes than those without upstaging. However, partial nephrectomy, compared with radical nephrectomy, showed comparable outcomes in patients who were up-staged.
ko_KR
dc.language.isoenko_KR
dc.publisherBioMed Centralko_KR
dc.subjectUpstagingko_KR
dc.subjectRenal cell carcinomako_KR
dc.subjectNephrectomyko_KR
dc.subjectSurvivalko_KR
dc.subjectStageko_KR
dc.titleOutcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomyko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이학민-
dc.contributor.AlternativeAuthor이민승-
dc.contributor.AlternativeAuthor이상은-
dc.contributor.AlternativeAuthor변석수-
dc.contributor.AlternativeAuthor김현호-
dc.contributor.AlternativeAuthor곽철-
dc.contributor.AlternativeAuthor홍성규-
dc.identifier.doi10.1186/s12885-018-4338-1-
dc.language.rfc3066en-
dc.rights.holderThe Author(s).-
dc.date.updated2018-04-22T03:31:37Z-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Urology (비뇨기과학전공)Journal Papers (저널논문_비뇨기과학전공)
Files in This Item:
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse